Real estate
Medtronic’s building permit for the new facility is valued at $900,000, with the listed architect as Thoda & Associates.
The financing was co-led by Advantech Capital and SDIC Venture Capital.
The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners.
The nearly 100-year-old medical-device business manufactures prosthetics and orthotics such as foot inserts and knee braces.
The entire 1.2 million-square-feet facility is expected to be finished in 2030.
The incubator will be located at Merck Serono’s current facilities in Yavne, a town in central Israel.
The new facility will add about 30 percent more capacity to Shire’s internal network.
Harpoon’s former CEO also hinted at possible growth at the office, including new hires for engineering and clinical team members.
Completed in two stages, the plant has begun operating fourteen 2,000 liter disposable bioreactors for fed-batch cell culture in the facility.
Spark Therapeutics is having a really good week in what has been a very good year.
PRESS RELEASES